Literature DB >> 28410338

Multiple Sources of Prescription Payment and Risky Opioid Therapy Among Veterans.

William C Becker1, Brenda T Fenton, Cynthia A Brandt, Erin L Doyle, Joseph Francis, Joseph L Goulet, Brent A Moore, Virginia Torrise, Robert D Kerns, Peter W Kreiner.   

Abstract

BACKGROUND: Opioid overdose and other related harms are a major source of morbidity and mortality among US Veterans, in part due to high-risk opioid prescribing.
OBJECTIVES: We sought to determine whether having multiple sources of payment for opioids-as a marker for out-of-system access-is associated with risky opioid therapy among veterans. RESEARCH
DESIGN: Cross-sectional study examining the association between multiple sources of payment and risky opioid therapy among all individuals with Veterans Health Administration (VHA) payment for opioid analgesic prescriptions in Kentucky during fiscal year 2014-2015. MEASURES: Source of payment categories: (1) VHA only source of payment (sole source); (2) sources of payment were VHA and at least 1 cash payment [VHA+cash payment(s)] whether or not there was a third source of payment; and (3) at least one other noncash source: Medicare, Medicaid, or private insurance [VHA+noncash source(s)]. Our outcomes were 2 risky opioid therapies: combination opioid/benzodiazepine therapy and high-dose opioid therapy, defined as morphine equivalent daily dose ≥90 mg.
RESULTS: Of the 14,795 individuals in the analytic sample, there were 81.9% in the sole source category, 6.6% in the VHA+cash payment(s) category, and 11.5% in the VHA+noncash source(s) category. In logistic regression, controlling for age and sex, persons with multiple payment sources had significantly higher odds of each risky opioid therapy, with those in the VHA+cash having significantly higher odds than those in the VHA+noncash source(s) group.
CONCLUSIONS: Prescribers should examine the prescription monitoring program as multiple payment sources increase the odds of risky opioid therapy.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28410338     DOI: 10.1097/MLR.0000000000000722

Source DB:  PubMed          Journal:  Med Care        ISSN: 0025-7079            Impact factor:   2.983


  10 in total

1.  Comparing cataract surgery complication rates in veterans receiving VA and community care.

Authors:  Amy K Rosen; Megan E Vanneman; William J O'Brien; Suzann Pershing; Todd H Wagner; Erin Beilstein-Wedel; Jeanie Lo; Qi Chen; Glenn C Cockerham; Michael Shwartz
Journal:  Health Serv Res       Date:  2020-07-27       Impact factor: 3.402

2.  Impact of a prescription drug monitoring program use mandate on potentially problematic patterns of opioid analgesic prescriptions in New York City.

Authors:  Marcus A Bachhuber; Ellenie Tuazon; Michelle L Nolan; Hillary V Kunins; Denise Paone
Journal:  Pharmacoepidemiol Drug Saf       Date:  2019-03-28       Impact factor: 2.890

3.  Patterns of Opioid Prescribing and Predictors of Chronic Opioid Use in an Industrial Cohort, 2003 to 2013.

Authors:  Mellisa A Pensa; Deron H Galusha; Linda F Cantley
Journal:  J Occup Environ Med       Date:  2018-05       Impact factor: 2.162

4.  A Typology of New Long-term Opioid Prescribing in the Veterans Health Administration.

Authors:  Katherine Hadlandsmyth; Hilary J Mosher; Emine O Bayman; Justin G Wikle; Brian C Lund
Journal:  J Gen Intern Med       Date:  2020-03-23       Impact factor: 5.128

5.  Advanced visualizations to interpret prescription drug monitoring program information.

Authors:  Scott G Weiner; Karen M Sherritt; Zoe Tseng; Jaya Tripathi
Journal:  Drug Alcohol Depend       Date:  2019-06-25       Impact factor: 4.492

6.  Linkage of VA and State Prescription Drug Monitoring Program Data to Examine Concurrent Opioid and Sedative-Hypnotic Prescriptions among Veterans.

Authors:  Kathleen F Carlson; Tess A Gilbert; Benjamin J Morasco; Dagan Wright; Joshua Van Otterloo; Aldona Herrndorf; Lawrence J Cook
Journal:  Health Serv Res       Date:  2018-08-07       Impact factor: 3.402

7.  Dual Use of Department of Veterans Affairs and Medicare Benefits on High-Risk Opioid Prescriptions in Veterans Aged 65 Years and Older: Insights from the VA Musculoskeletal Disorders Cohort.

Authors:  Philip W Chui; Lori A Bastian; Eric DeRycke; Cynthia A Brandt; William C Becker; Joseph L Goulet
Journal:  Health Serv Res       Date:  2018-10-08       Impact factor: 3.402

8.  Receipt of Overlapping Opioid and Benzodiazepine Prescriptions Among Veterans Dually Enrolled in Medicare Part D and the Department of Veterans Affairs: A Cross-sectional Study.

Authors:  Ron Carico; Xinhua Zhao; Carolyn T Thorpe; Joshua M Thorpe; Florentina E Sileanu; John P Cashy; Jennifer A Hale; Maria K Mor; Thomas R Radomski; Leslie R M Hausmann; Julie M Donohue; Katie J Suda; Kevin Stroupe; Joseph T Hanlon; Chester B Good; Michael J Fine; Walid F Gellad
Journal:  Ann Intern Med       Date:  2018-10-09       Impact factor: 25.391

9.  Prescription Opioid Quality Measures Applied Among Pennsylvania Medicaid Enrollees.

Authors:  Gerald Cochran; Wei-Hsuan Lo-Ciganic; Walid F Gellad; Adam J Gordon; Evan Cole; Carroline Lobo; Winfred Frazier; Ping Zheng; Chung-Chou H Chang; David Kelley; Julie M Donohue
Journal:  J Manag Care Spec Pharm       Date:  2018-09

10.  High-dose prescribed opioids are associated with increased risk of heroin use among United States military veterans.

Authors:  Geetanjoli Banerjee; E Jennifer Edelman; Declan T Barry; Stephen Crystal; Kirsha S Gordon; Adam J Gordon; Julie R Gaither; Traci C Green; Robert D Kerns; Ajay Manhapra; Brent A Moore; David A Fiellin; Brandon D L Marshall
Journal:  Pain       Date:  2019-09       Impact factor: 7.926

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.